Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab

Adv Respir Med. 2020;88(5):468-469. doi: 10.5603/ARM.a2020.0123.

¹ Clinical Pharmacy Department, Tehran University of Medical Sciences, Tehran, Iran.
² Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, Iran.
⁴ Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
⁵ Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ardakiani@sbmu.ac.ir.

No abstract available

Keywords: COVID-19; interleukin-6; tocilizumab.

Publication types